Clinical trial
Effectiveness of Retrolaminar Block in Reducing Postoperative Opioid Consumption in Patients Undergoing Lumbar Spine Fusion With Multimodal Analgesia
NCT07291388 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Retrolaminar Block in Reducing Postoperative Opioid Consumption in Patients Undergoing Lumbar Spine Fusion With Multimodal Analgesia
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- March 31, 2027
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pain, anesthesia, lumbar spine disease